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ABSTRACT
The tripartite motif (TRIM) proteins constitute a family of ubiquitin
E3 ligases involved in a multitude of cellular processes, including
protein homeostasis and autophagy. TRIM32 is characterized by
six protein–protein interaction domains termed NHL, various point
mutations in which are associated with limb-girdle-muscular
dystrophy 2H (LGMD2H). Here, we show that TRIM32 is an
autophagy substrate. Lysosomal degradation of TRIM32 was
dependent on ATG7 and blocked by knockout of the five autophagy
receptors p62 (also known as SQSTM1), NBR1, NDP52 (also known
as CALCOCO2), TAX1BP1 and OPTN, pointing towards degradation
by selective autophagy. p62 directed TRIM32 to lysosomal
degradation, while TRIM32 mono-ubiquitylated p62 on lysine
residues involved in regulation of p62 activity. Loss of TRIM32
impaired p62 sequestration, while reintroduction of TRIM32 facilitated
p62 dot formation and its autophagic degradation. A TRIM32LGMD2H
disease mutant was unable to undergo autophagic degradation and
to mono-ubiquitylate p62, and its reintroduction into the TRIM32-
knockout cells did not affect p62 dot formation. In light of the important
roles of autophagy and p62 in muscle cell proteostasis, our results
point towards impaired TRIM32-mediated regulation of p62 activity as
a pathological mechanisms in LGMD2H.
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INTRODUCTION
Protein quality control is crucial for cellular health, especially in
tissues containing long-lived cells like the muscles and nervous
system. Dysfunctional quality control leads to protein aggregation
and development of diseases with increasing prevalence related to age
(Dikic and Elazar, 2018). The two most important biological
machineries controlling protein degradation are autophagy and the
ubiquitin-proteasome system (UPS), where protein ubiquitylation
mediated by E3 ubiquitin ligases provide substrate specificity. Based
on their structural properties, E3 ubiquitin ligases are classified as
RING, HECT or RBR ligases (Morreale and Walden, 2016). TRIM
family proteins belong to the RING E3s, which constitute the most-
abundant family of ubiquitin ligases (Hatakeyama, 2017). TRIMs are
characterized by the highly conserved RING finger–B-box–coiled-
coil domains at their N-termini, generally constituting their E3 ligase
and oligomerization activity. Human TRIM family proteins comprise
82members that are classified into 12 different subfamilies according
to the domain structure of their C-terminal region (Fig. 1A). They
have important functions in development, differentiation, immune
responses and carcinogenesis (reviewed in Hatakeyama, 2017).
Furthermore, certain TRIM proteins act as regulators of autophagy
activity (Pizon et al., 2013; Tomar et al., 2012) and as autophagy
receptors (Chauhan et al., 2016; Kimura et al., 2015, 2016; Mandell
et al., 2016, 2014). TRIM32 is characterized by six repeats of NHL
(NCL-1, HT2A and LIN-41) motifs in its C-terminus, which are
thought to mediate protein–protein interactions (Slack and Ruvkun,
1998). TRIM32 is expressed throughout the body, but with high
expression levels in the brain and heart (Frosk et al., 2002). The
biological roles of TRIM32 are multi-faceted, impacting muscle
physiology, cancer and immunity. This is reflected in the many
substrates reported to be targeted by its E3 ligase activity, such as the
muscular relevant proteins actin, α-actinin, desmin, tropomysin and
dysbindin, the cell cycle regulators c-Myc, MYCN and p53, and the
innate immunity adaptor STING (also known as TMEM173)
(reviewed in Lazzari and Meroni, 2016). The finding that mutations
in the NHL domains of TRIM32 can lead to the hereditary muscular
disease limb-girdle muscular dystrophy 2H (LGMD2H), identified
TRIM32 as an important player in muscular physiology (Frosk et al.,
2002).Whether the pathogenic effect of LGMD2H is due to a role for
TRIM32 in muscle atrophy (Cohen et al., 2012) or more in muscle
homeostasis and regrowth after atrophy (Kudryashova et al., 2012,
2005; Nicklas et al., 2012; Servián-Morilla et al., 2019) is not well
understood. However, it has been shown that the LGMD2Hmutations
lead to impaired self-oligomerization and auto-ubiquitylation, and
reduced TRIM32 expression level (Albor et al., 2006; Kudryashova
et al., 2011; Locke et al., 2009; Servián-Morilla et al., 2019).
Moreover, recent work analyzing muscle biopsies and primary
myoblasts from LGMD2H patients, described reduced proliferation
and differentiation capacity, diminished satellite cell pool, and
enhanced senescence and autophagy activity (Servián-Morilla et al.,
2019). In addition, another very recent publication reported that
TRIM32 is important for induction of autophagy in atrophic muscle
cells, while the LGMD2Hmutant was unable to activate autophagy in
these cells (Di Rienzo et al., 2019). All mutations associated with
LGMD2H are either deletions or point mutations located in the
NHL domains, while a point mutation in the B-box of TRIM32 is
associated with a completely unrelated disease, multisystemic disorderReceived 15 July 2019; Accepted 28 October 2019
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Bardet–Biedl syndrome 11 (BBS11) (Chiang et al., 2006). The
pathogenic mechanism for the disease is not understood.
Autophagy is a cellular renovation system that uses lysosome-
mediated pathways to degrade and recycle almost any type of cell
content (Mizushima and Komatsu, 2011). Autophagy is described to
act both as a non-selective bulk degradation pathway, and as a
selective elimination of components such as aberrant protein
aggregates, RNA bodies, lipid droplets, unwanted organelles and
invading pathogens in a process termed selective autophagy (reviewed
in Rogov et al., 2014). Selective autophagy provides quality control of
cellular components, degrading damaged and harmful material during
normal cellular conditions. When cells are stressed by hypoxia,
ischemia, starvation or infection, selective autophagy is stimulated and
specifically targets excess or toxic structures (Johansen and Lamark,
2011; Rogov et al., 2014). This allows the cell to adapt to the
unfavorable conditions. Autophagy receptors are instrumental in the
process. They bind specifically to the cargo and to ATG8 family
proteins (such as LC3B, also known as MAP1LC3B) at the forming
autophagosome, directing the cargo for degradation in the lysosome.
The first selective autophagy receptor to be identified was p62, also
known as sequestosome-1 (SQSTM1) (Bjørkøy et al., 2005).
Ubiquitin labeling is one of the signals for cargo degradation via
selective types of autophagy. Ubiquitylated protein aggregates
containing autophagy receptors are evident in a range of human
diseases. p62 contains a C-terminal ubiquitin-binding domain (UBA),
a LC3-interacting region (LIR) and an N-terminal Phox and Bem1
(PB1) domain with an oligomerization property (Pankiv et al., 2007).
The oligomerization activity of p62 is important for sequestering its
cargo and for scaffolding phagophore membrane development
(Bjørkøy et al., 2005; Itakura and Mizushima, 2011), described as a
p62-mediated phase separation process dependent on ubiquitin (Sun
et al., 2018; Zaffagnini et al., 2018). Recent studies have revealed that
the autophagy activity of p62 itself is regulated by ubiquitylation
(Heath et al., 2016; Jongsma et al., 2016; Lee et al., 2017; Pan et al.,
2016; Peng et al., 2017). The UBA domain of unmodified p62 has a
strong tendency to form an intermolecular dimer that spatially
occludes ubiquitin binding (Isogai et al., 2011; Long et al., 2010).
Ubiquitylation of several residues both inside and outside the UBA
domain is reported to enhance the ubiquitin-binding activity and
autophagy activity of p62 (Lee et al., 2017; Peng et al., 2017).
Interestingly, several studies implicate p62 as an important player of
protein homeostasis in muscle cells (Arndt et al., 2010; Lee et al.,
2018; Rodriguez-Muela et al., 2018). Furthermore, proper regulation
of autophagy is fundamental for muscle homeostasis, and
dysregulation of autophagy has a pathogenic role in several forms
of muscle diseases (Jiao and Demontis, 2017).
By employing a fluorescence-based double-tag screen of 22
TRIM proteins representing each of the TRIM subfamilies, we
identified TRIM32 as a potential autophagy cargo protein.
Interaction analysis in vitro and in cells revealed direct interaction
and colocalization of TRIM32 and p62, while autophagy assays
showed that p62 was able to mediate autophagic degradation of
TRIM32. Conversely, ubiquitylation assays and proteomic analysis
identified p62 as a TRIM32 substrate. TRIM32 mediated mono-
ubiquitylation of p62 at residues previously shown to be important
for the ubiquitin-binding activity of p62. By establishment of
TRIM32-knockout (KO) and reconstituted cells, we show that
TRIM32 facilitates p62 sequestration and autophagic degradation.
Introduction of the LGMD2H disease mutation in TRIM32 inhibited
its autophagic degradation, and also its ability to regulate p62
Fig. 1. TRIM proteins from various subclasses are degraded in the lysosome. (A) Subclasses and domain organization of the 22 TRIM proteins
analyzed in the double-tag screen. The ability of each mCherry–EYFP–TRIM protein to form RedOnly structures is indicated by ND (no RedOnly structures
detected),+(<10 RedOnly structures in cells with fluorescent puncta), ++ (many RedOnly structures in cells with fluorescent puncta). R, Ring finger B1/B2: Bbox1/
Bbox2; CC, Coiled coil. (B) Confocal images of mCherry–EYFP-tagged TRIM proteins representing each of the categories ND, + and ++. HeLa cells were
transfected with mCherry–EYFP-tagged TRIM22, TRIM31 or TRIM32 1 day before fixation and imaged using a Zeiss780 confocal microscope and the Zen
software. Blue, DAPI staining. Scale bars: 10 µm.
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activity. In contrast, introduction of the BBS11 mutation in TRIM32
strongly facilitated p62 sequestration and degradation. Our results
demonstrate a dual role for TRIM32 in autophagy, acting both as a
substrate and as a positive regulator of p62. Importantly, the
inactivity of the TRIM32 LGMD2H mutant points toward
dysfunctional TRIM32 mediated regulation of p62 as a
pathological mechanism in LGMD2H.
RESULTS
TRIM proteins from various subclasses are degraded in
the lysosome
Recent studies have shown that certainTRIMproteins are implicated in
the autophagy process, as regulators and as receptors in selective
autophagy (reviewed in Di Rienzo et al., 2019; Hatakeyama, 2017;
Kimura et al., 2017, 2016; van Gent et al., 2018). Furthermore, a few
TRIM proteins seemingly are degraded by autophagy themselves,
including TRIM50 (Fusco et al., 2012), TRIM30 (Choi et al., 2015)
and TRIM5α (Mandell et al., 2016). Here, we employed the double-
fluorescence-tag strategy (Pankiv et al., 2007) to identify TRIM
proteins that could be degraded by autophagy, and hence that are
potential as autophagy regulators and receptors. A total of 22 different
TRIM proteins, representing 11 subclasses of the TRIM family, were
fused to the double fluorescence tag mCherry–EYFP and expressed in
HeLa cells. Since EYFP is unstable in acidic milieus with a pH below
6, while mCherry is stable, double-tagged proteins will only have red
florescence when they are sequestered in the lysosome (denoted
‘RedOnly’ structures), which has a pH of ∼4.7. At 24 h after
transfection, the cells were exposed to normal medium or were starved
for 2 h in Hanks’ balanced salt solution (HBSS), before fixation and
confocal microscopy imaging. To verify that the RedOnly structures
represented lysosomal compartments, we analyzed, in parallel, cells
treated with the lysosomal inhibitor Bafilomycin A1 (BafA1) for 4 h
before fixation. BafA1 impairs the acidification of the lysosomes, and
hence the quenching of EYFP localized in the lysosome. As presented
in Fig. 1, 13 of the 22 TRIM proteins tested formed some RedOnly
structures. Nine of these have previously been linked to autophagy,
namely, TRIM20 and TRIM21 (Kimura et al., 2015), TRIM50 (Fusco
et al., 2012), TRIM23 (Sparrer et al., 2017), TRIM13 (Tomar et al.,
2012), TRIM31 (Ra et al., 2016), TRIM5α (Mandell et al., 2014),
TRIM32 (Di Rienzo et al., 2019; Yang et al., 2017) and TRIM16
(Chauhan et al., 2016;Kimura et al., 2017). Theobservation that not all
TRIM proteins form RedOnly structures may indicate that this is not a
general trait of the conserved N-terminal RING finger–B-box–coiled-
coil domains, or that degradation of certain TRIMs by autophagy is
dependent on factors not present in HeLa cells. Furthermore, RedOnly
structures were detected among TRIMs from many different
subclasses (Fig. 1A), suggesting that it is not dependent on any
specific domains in the C-terminal. However, four of the six TRIM
proteins that gave a substantial amount of RedOnly structures both in
normal medium and upon starvation conditions contain a SPRY
domain in their very C-terminal end. Three of these, TRIM5α,
TRIM16 and TRIM20, have been previously identified as autophagy
receptors (Chauhan et al., 2016; Kimura et al., 2017; Mandell et al.,
2014) and hence confirm our screening strategy. mCherry–EYFP–
TRIM32 displayed a strong and reproducible formation of RedOnly
dots in both normal and starved conditions (Fig. 1B). Interestingly,
TRIM32 is reported to interactwith the autophagy receptorTAX1BP1,
and thereby mediate autophagic degradation of the TLR3/4 adaptor
protein TRIF (Yang et al., 2017) and a recent report suggests
autophagic degradation of the TRIM32 LGMD2H disease mutants
(Servián-Morilla et al., 2019). However, whether TRIM32 is a
substrate for autophagic degradation is unresolved.
TRIM32 interacts and colocalizes with the autophagy
marker proteins LC3B and p62
The double tag assay clearly indicated lysosomal degradation of
exogenous TRIM32. In order to determine whether endogenous
TRIM32 is degraded via lysosomal pathways or via the proteasome,
the lysosomal inhibitor BafA1 and the proteasomal inhibitor MG132
were applied on HEK293 cells grown in full medium or starved in
HBSS for 4 h. The protein levels of endogenous TRIM32 during the
various conditions was analyzed by western blotting and the band
intensities quantitated and correlated to the level of PCNA (Fig. 2A).
Treatment with the lysosomal inhibitor and the proteasomal inhibitor
increased the amount of TRIM32 to a similar degree under starvation
conditions, while the proteasomal pathway seems to be most
important under normal cellular conditions. The increase of the
LC3B II band (representing lipidated LC3B) upon BafA1 treatment,
and the phosphorylation status of the mTOR-regulated translation
initiation factor 4E (p4E-BP1) verified that the cells responded as
expected to the lysosomal inhibitor and to the starvation medium.
These data suggest that TRIM32 is degraded via the proteasomal and
lysosomal pathways to a similar extent during starvation conditions,
while the proteasomal pathway is dominant under normal conditions.
Several TRIM proteins are reported to interact with core
components of the autophagy machinery, and to function as
autophagy receptors and regulators of autophagosome formation
(Kimura et al., 2015, 2016; Mandell et al., 2016, 2014). We applied
in vitroGST-pulldown assays to determine whether TRIM32 has the
ability to bind directly to the ATG8 family proteins. Fig. 2B shows
that TRIM32 binds to LC3A (MAP1LC3A), LC3C (MAP1LC3C),
GABARAP and GABARAP-L1, and weakly to LC3B and
GABARAP-L2. However, we were not able to find any candidate
LC3-interacting regions (LIRs) in TRIM32 with bioinformatic tools,
and GST-pulldown assays with the N-terminal part of TRIM32
(the RING finger–B-box–coiled-coil domains) and the C-terminal
part (NHL-domains) both displayed binding to GST–LC3B and
GST–GABARAP (Fig. S1A). Further attempts to identify LIRs in
TRIM32 did not give any consistent results (data not shown). We
next tried to identify whether the interaction between TRIM32 and
the ATG8 protein family was mediated by the newly characterized
ubiquitin-interacting motif (UIM) docking site (Marshall et al.,
2019). However, we were not able to identify a UIM motif in
TRIM32. This suggests that TRIM32 can interact directly with
ATG8 proteins in a non-LIR- and non-UIM-dependent way,
suggesting that other or more complex interfaces are involved.
To further investigate the lysosomal degradation of the TRIM32
mutants, Flp-In T-Rex 293 cell lines with tetracycline-inducible
expression of EGFP–TRIM32P130S and EGFP–TRIM32D487N were
established (Fig. S1B). In accordance with previous reports,
TRIM32 is normally a cytoplasmic protein forming distinct
perinuclear bodies or aggregates (Fig. 2C; Fig. S1B) (Locke et al.,
2009). Furthermore, western blots of the expressed EGFP fusion
proteins revealed a slower-migrating form of EGFP–TRIM32 and
the BBS11 mutant EGFP–TRIM32P130S, but not the LMGD2H
mutant EGFP–TRIM32D487N (Fig. S1B). Co-staining the FlpIn
EGFP–TRIM32 cells with antibodies against the autophagy marker
protein LC3B and the autophagy receptor protein p62 showed that
certain TRIM32 bodies colocalized with LC3B-positive p62
bodies (Fig. 2C). This indicates that a subpopulation of the
TRIM32 bodies represent autophagosomes. Such bodies were
observed both in full medium and in starvation conditions. To
further evaluate whether TRIM32 interacts with p62 in cells, the
DuoLink proximity ligation assay was employed to detect close
colocalization of EGFP–TRIM32 and endogenous p62 in the Flp-In
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EGFP–TRIM32 cell line. The DuoLink assay revealed close to 30
distinct spots per cell (Fig. 2D). Together, these data show that
TRIM32 is recruited to LC3B-positive p62 bodies, and is stabilized
by treating cells with the lysosomal inhibitor BafA1. This strongly
indicates that a subpopulation of TRIM32 proteins is degraded by
autophagy.
Seven various mutations in the NHL repeat region of TRIM32
are associated with the recessive muscular dystrophy disease
LGMD2H, with the TRIM32D487N mutation being the most
common (Fig. 2E) (Frosk et al., 2002), while a point mutation in
the B-Box2, TRIM32P130S, leads to the pleiotropic disorder
BBS11 (Fig. 2E) (Chiang et al., 2006). We applied the in vitro
Fig. 2. See next page for legend.
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GST-pulldown assay to verify the direct interaction between p62
and wild-type TRIM32 and its two disease mutants. p62 expressed
in E.coli and immobilized on glutathione beads was added to
in-vitro-translated Myc–TRIM32WT, Myc–TRIM32P130S or Myc–
TRIM32D487N. The amount of bound proteins was analyzed by
SDS-PAGE (Fig. 2E). Wild-type TRIM32 and both its disease
mutants bound weakly to p62. The interaction between TRIM32
and p62 in cells was further confirmed by GST-pulldown assays
using cell extracts from HEK293 cell lines expressing EGFP-tagged
wild-type TRIM32 and its disease mutants (Fig. 2F), and by
co-immunoprecipitation of endogenous p62 (Fig. S1D).
The PB1 domain and the UBA domain of p62 is important for p62
oligomerization and for binding to ubiquitylated proteins (Bjørkøy
et al., 2005; Lee et al., 2017). In order to identify whether the PB1
domain or the UBA domain of p62 is implicated in the interaction
with TRIM32, we performed GST-pulldown assays using p62 PB1
and UBA deletion constructs fused to GST and cell extracts from
cells expressing exogenous EGFP–TRIM32. We found that deletion
of the UBA domain or the PB1 domain did not affect the interaction
with TRIM32, indicating that the interaction is not mediated by
ubiquitin (Fig. 2G). These results show that TRIM32 binds directly
to the autophagy receptor p62, and this interaction is not impaired by
the LGMD2H and BBS11 disease mutations.
TRIM32 is targeted to autophagic degradation by p62
Next, we evaluated whether the lysosomal degradation of TRIM32
is mediated by macroautophagy. For this purpose, we applied the
mCherry–EYFP–TRIM32 double-tag assay in the autophagy-
deficient ATG7-KO cells (Mejlvang et al., 2018). ATG7 is an
ubiquitin E1-like activating enzyme that is essential for assembly
and function of the ubiquitin-like conjugation systems (Nakatogawa
et al., 2009). mCherry–EYFP–TRIM32 did not form any RedOnly
dots in the ATG7-KO cells (Fig. 3A,C). Furthermore, degradation of
endogenous TRIM32 was not stabilized by BafA1 treatment in
ATG7-KO cells (Fig. 3B). This clearly indicates that lysosomal
degradation of TRIM32 is mediated by the macroautophagy
pathway. Next question was whether TRIM32 is degraded by
selective autophagy. To this end, the degradation of TRIM32 was
assayed in a cell line lacking the five autophagy receptors p62,
NBR1, NDP52, TAX1BP1 and OPTN (denoted the ‘pentaKO’)
(Lazarou et al., 2015). Only a few cells with mCherry–EYFP–
TRIM32 RedOnly dots were observed in pentaKO cells grown
under normal and starvation conditions (Fig. 3A,C). This suggests
that TRIM32 is dependent on the autophagy receptors for efficient
degradation by autophagy, pointing towards degradation by
selective autophagy.
The interaction and colocalization of TRIM32with p62 prompted
us to analyze the degradation of TRIM32 in pentaKO cells
reconstituted with EGFP–p62. mCherry–EYFP–TRIM32 formed
several RedOnly dots both under normal and starvation conditions
in this cell line, indicating that p62 is able to mediate autophagic
degradation of TRIM32 (Fig. 3C,D). To evaluate if p62 is essential
for autophagic degradation of TRIM32, we employed the double tag
assay in a HEK293 FlpIn cell line knocked out for p62. The T-REx
HEK293 p62−/− cell line was established by CRISPR/Cas9 as
described in theMaterials andMethods section (Fig. S1C). Ablation
of p62 strongly reduced the number of RedOnly dots in the
mCherry–EYFP–TRIM32-transfected cells compared to wild-type
cells (Fig. 3C,D), but did not completely abolish lysosomal
degradation of mCherry–EYFP–TRIM32. This indicates that p62
can mediate autophagic degradation of TRIM32. However, other
autophagy receptors beside p62 may also be involved.
The LGMD2H disease mutant of TRIM32 is not degraded by
autophagy
To investigate whether the TRIM32P130S and TRIM32D487N disease
mutants were degraded by autophagy, they were fused to the
mCherry–EYFP double tag and transfected into HeLa cells.
Interestingly, we found that mCherry–EYFP–TRIM32P130S
displayed a strong ability to form RedOnly dots, especially under
starvation conditions (Fig. 4A). TRIM32D487N on the other hand,
wasmainly diffuse except from in some cells where it formed several
round dots distributed throughout the cell. However, none of these
dots were found to be RedOnly (Fig. 4A). Similar results were
obtained when we transfected the double-tag constructs into the
myoblast cell line C2C12 (Fig. S2A). Around 75% of the C2C12
cells expressingmCherry–EYFP–TRIM32WT andmCherry–EYFP–
TRIM32P130S contained RedOnly dots, compared to only 12% of the
C2C12 cells expressing mCherry–EYFP–TRIM32D487N. Moreover,
double-tag analyses in the C2C12 cells expressing the mutants
TRIM32R394H and TRIM32V591M, both of which arewithin theNHL
repeats region and are associated with LGMD2H, revealed that they
did not localize in acidic compartments (Fig. S2A). These results
clearly indicate that TRIM32 undergoes autophagic degradation in
muscle cells, and that this degradation is strongly inhibited by
mutations associated with LGMD2H.
Fig. 2. TRIM32 interacts and colocalizes with the autophagy marker
proteins LC3B and p62. (A) HEK293 FlpIn cells were treated with BafA1
(200 nM) or MG132 (10 µM) for 4 h in HBSS (starvation medium, SM) or full
medium (FM), before cell extracts were harvested in 1× SDS. 10 µg of the
various cell extracts were separated on SDS-PAGE gels and blotted against
the indicated antibodies. The bar graphs on top panel represent the mean±
s.e.m. relative band intensities estimated by ImageJ from three independent
experiments (n=3). *P<0.05, ***P<0.0005 (Student’s t-test). (B) GST-pulldown
assay using 35S-labeled Myc–TRIM32 and recombinant GST and GST–ATG8
proteins. The amount of Myc–TRIM32 bound to the various ATG8 proteins was
detected by autoradiography. The assay was repeated with similar results.
(C) HEK293 FlpIn EGFP-TRIM32 cells in full medium or starved in HBSS
(2 h) were fixed and stained with antibodies for LC3B and p62. Images were
obtained using a ZEISS780 confocal laser scanning microscope, and the
colocalization monitored using the ZEN software. Scale bars: 10 µm (main
images), 2 µm (magnifications). Intensity profiles along the indicated line are
shown to the right. (D) Representative images of the Flp-In EGFP-TRIM32
cells analyzed by the proximation ligation assay DuoLink using antibodies
against GFP and p62. The graph represents the mean±s.d. of colocalization
dots using the Volocity software, from three independent experiments. Each
experiment includes z-stack images of n=100 cells per condition. Scale bars:
10 µm. (E) The top panel shows a schematic of the TRIM32 domain
organization with the localization of the disease point mutations P130S and
D487N indicated. R, Ring finger; B2, Bbox2; CC, Coiled coil. The lower panels
show GST-pulldown assays using 35S-labeled Myc–TRIM32WT, Myc–
TRIM32P130S or Myc–TRIM32D487N and recombinant GST and GST–p62
immobilized on glutathione–Sepharose beads. Quantifications of the binding
of wild-type and mutant constructs to GST–p62 are presented as percentage
binding relative to input. The bars represent the mean±s.d. band intensities
compared to input as quantified using ImageJ of three independent
experiments. *P=0.025; n.s., not significant (Student’s t-test).
(F) GST-pulldown assay using cell extracts from FlpIn EGFP-TRIM32WT,
EGFP-TRIM32P130S or EGFP-TRIM32D487N cells and GST–p62 immobilized
on glutathione–Sepharose beads. EGFP–TRIM32 was detected using an
anti-GFP antibody. GST proteins were visualized by Ponceau staining.
Quantifications of the band intensities of the bound proteins compared to 5%
input are indicated below the blot. (G) GST-pulldown assays using cell extracts
from the FlpIn EGFP–TRIM32 cells and recombinant GST, GST-p62, or
various GST-p62 deletion constructs immobilized on glutathione–Sepharose
beads. Bound EGFP–TRIM32 was detected using anti-GFP antibody, while
the GST proteins were visualized by Ponceau staining. Quantifications of the
band intensities of the bound proteins compared to 5% input using ImageJ are
indicated below the blot.
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Fig. 3. TRIM32 is targeted to autophagic degradation by p62. (A) Normal HeLa cells and cells that were genetically knocked out for ATG7 or the five autophagy
receptors p62, NBR1, NDP52, OPTN or TAX1BP1 (pentaKO) as indicated, were transfected with mCherry–EYFP–TRIM32. At 1 day post transfection, half
of the cells were treated with HBSS for 2 h (starvation medium, SM) and half were maintained in full medium (FM), before all cells were fixed, stained with DAPI
and imaged using a Zeiss780 confocal microscope. Scale bars: 10 µm. (B)Western blot analysis of endogenous TRIM32 in wild-type HeLa cells and HeLa ATG7-
KO cells in normal medium (FM) in HBSS (SM), and treated or not with BafA1 (Baf) and MG132 (MG) for 4 h. The graph represents the mean±s.d. TRIM32 band
intensities from three independent experiments quantitated using ImageJ. P-values are obtained using Student’s t-test. n.s.=not significant (P-value>0.05).
PCNA represents the loading control, while p62 and LC3B are controls of autophagy flux. (C) The graphs represent the amount of mCherry-EYFP-TRIM32
transfected cells that contain RedOnly dots compared to the amount of cells that display mCherry-EYFP-TRIM32 dots (representative images shown in A and D)
under normal and starvation (HBSS 2 h) conditions. Each graph represents themean±s.e.m. of at least three independent experiments (n=25–50 cells). *P<0.05,
**P<0.005, ***P<0.0005, n.s., not significant (Student’s t-test). (D) PentaKO cells reconstituted with GFP–p62 (green dots) and HEK293 FlpIn cells genetically
knocked out for p62 as indicated to the right, were transfected and treated as described in A. Scale bars: 10 µm.
6













Fig. 4. The LGMD2H disease mutant of TRIM32 is not degraded by autophagy. (A) HeLa cells were transfected with mCherry–EYFP–TRIM32WT,
mCherry–EYFP–TRIM32P130S or mCherry–EYFP–TRIM32D487N as indicated, kept in normal medium (full medium, FM) or starved with HBSS for 2 h (starvation
medium, SM) at 1 day post transfection and imaged bya Zeiss780 confocal microscope. The graphs to the right displaymanual quantification of RedOnly dots and
yellow dots in n=30 cells, and are representative of three independent experiments. Scale bars: 10 µm. (B) GFP fluorescence intensities (arbitrary units) of
EGFP–TRIM32WT, EGFP–TRIM32P130S and EGFP–TRIM32D487N asmeasured by flow cytometry 24 h after promoter shut off in full medium (FM) or HBSS for 6 h
(SM), supplemented with BafA1 2 µm (Baf) or MG132 20 µM (MG) as indicated. Bars show average mean±s.d. GFP intensity from three independent
experiments (n=10,000 cells). P-values are as indicated; n.s., not significant (Student’s t-test). (C) Representative images of the Flp-In EGFP-TRIM32 cells
analyzed by the proximation ligation assay DuoLink using antibodies against GFPand p62. The graph represents the mean±s.d. relative number of colocalization
dots with from three independent experiments. Each experiment includes z-stack images of n≈100 cells per condition, and was quantified using the Volocity
software. P-values are as indicated; n.s., not significant (Student’s t-test). Scale bars: 10 µm.
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Next, a flow-based reporter cell system (Larsen et al., 2010) was
applied on the HEK293 FlpIn EGFP–TRIM32 cell lines, to monitor
degradation of EGFP–TRIM32 and the two disease mutants under
normal conditions and starvation. Expression of EGFP–TRIM32 or
the disease mutants was induced by treatment with tetracycline for
24 h. Thereafter, the expression was shut off by tetracycline wash-
out. The cells were starved in HBSS for 6, 12 and 24 h, and the
degradation measured by flow cytometry using the mean GFP
intensity in the cell population as a read out. BafA1 was applied to
determine degradation by lysosomal pathways, while MG132 was
included to measure proteasomal degradation. In full medium,
EGFP–TRIM32 is stabilized to a similar extent by BafA1 and
MG132, implicating both autophagy and the proteasome system in
TRIM32 degradation under normal conditions (Fig. 4B). This is in
line with the data presented in Fig. 2A, showing that endogenous
TRIM32 is degraded both by autophagy and by the proteasome.
This shows that EGFP–TRIM32 inducibly expressed in FlpIn cell
lines is degraded similarly to the endogenous protein. Upon 6 h
starvation, EGFP–TRIM32 expression is reduced by 85% compared
to normal conditions. The degradation is inhibited both by BafA1
and MG132, pointing towards involvement of both autophagy and
the proteasomal system also under starved conditions. Similar
results were obtained when the starvation period was extended to 12
and 24 h (data not shown). However, the expression level of EGFP–
TRIM32 did not decline further, indicating that the expression of
TRIM32 is stabilized after 6 h starvation. Applying the flow reporter
assay on the BBS11 disease mutant EGFP–TRIM32P130S indicated
a higher rate of degradation compared to the wild-type protein, with
a 90% reduction in the expression after 6 h of starvation (Fig. 4B).
The LGMD2H disease mutant EGFP–TRIM32D487N, however, was
not stabilized by BafA1 treatment under either normal or starvation
conditions (Fig. 4B). The expression level of EGFP–TRIM32D487N
upon starvation is reduced by 50%, which indicates a dramatically
lower turnover than the wild-type protein and the BBS11 mutant.
Hence, as indicated by the double-tag assay in Fig. 4A, EGFP–
TRIM32D487N is not an autophagic substrate, suggesting that it
shows dependence on its oligomerization and/or auto-mono-
ubiquitylation abilities to be recognized as an autophagic
substrate. This is in contrast to a recent report showing BafA1-
mediated stabilization of a TRIM32 LGMD2H mutant in primary
myoblasts isolated from a patient (Servián-Morilla et al., 2019).
This discrepancy can be explained by a TRIM32V591M mutation in
this patient, while we have analyzed the TRIM32D487N mutation.
Since we found that TRIM32 colocalizes with p62 in punctate
structures, and that reintroduction of p62 into the pentaKO cells was
sufficient to direct TRIM32 to autophagic degradation, the next
question was whether EGFP–TRIM32D487N had lost its ability to
interact with endogenous p62. To this end, the Duolink proximation
ligation assay was performed on the FlpIn EGFP–TRIM32
wild-type and mutant cell lines (Fig. 4C). Importantly, EGFP–
TRIM32D487N colocalized with p62 to a similar extent as
EGFP–TRIM32WT. Hence, interaction with p62 is not sufficient
to target TRIM32 to autophagic degradation. Interestingly, the
BBS11 disease mutant interacted strongly with p62, forming around
twice as many dots in the Duolink assay as wild-type TRIM32
(Fig. 4C). This suggests that the P130S mutation in TRIM32 may
modulate the colocalization of TRIM32 and p62 in cells.
Wild-type TRIM32, but not the LGMD2H disease mutant,
mono-ubiquitylates p62
In order to investigate the role of TRIM32 in selective autophagy,
we established HEK293 FlpIn TRIM32-KO cell lines by CRISPR/
Cas9. Knockout of TRIM32 expression in the cell lines was verified
by western blotting (Fig. S2B) and genomic sequencing (Fig. S2C).
Measuring the proliferation curve of the TRIM32-KO cell lines
revealed that they had impaired proliferation compared to the
mother HEK293 FlpIn cell line (Fig. 2D). This is in line with the
reported roles of TRIM32 in tumorigenesis (Liu et al., 2014; Wang
et al., 2018; Yin et al., 2018; Zhao et al., 2018), and thus validates
the TRIM32-KO cell lines further.
Recent research connects the upregulation of TRIM proteins in
tumor cells to enhanced protein quality control and antioxidant
defense (Chen et al., 2017). p62 plays important roles both in
protein quality control and in antioxidant defense via NRF2 (also
known as NFE2L2) (Jain et al., 2010; Pankiv et al., 2007), and
ubiquitylation is an important signaling event in these processes.
Moreover, reports describing ubiquitin modifications of p62 as a
modulator of its activity are emerging (Heath et al., 2016; Jongsma
et al., 2016; Lee et al., 2017; Lin et al., 2017; Pan et al., 2016). This
prompted us to investigate whether TRIM32 has the ability to
ubiquitylate p62. Myc–p62 was immunoprecipitated from a
HEK293 p62-KO cell line co-expressing Myc–p62 and EGFP–
TRIM32. Western blotting revealed a slow-migrating band both for
Myc–p62 and EGFP–TRIM32 (Fig. 5A), indicative of mono-
ubiquitylation of both proteins. Whether these slower migrating
bands indeed represented ubiquitin modification was verified by
coexpressing the de-ubiquitylase USP2 (Fig. 5B). Expressing USP2
removed the slow-migrating band of both p62 and TRIM32.
Furthermore, such slower-migrating bands were not detected
when Myc–p62 was precipitated from HEK293 cells expressing
EGFP–TRIM32C44S (catalytic dead) or EGFP–TRIM32D487N (an
LGMD2H disease mutation). This indicates that TRIM32 mediates
mono-ubiquitylation of p62, and that this is impaired by mutations
in the NHL domains involved in the LGMD2H disease. Mutation in
the BBox2 (P130S, a BBS11 disease mutation), however, did not
affect mono-ubiquitylation of p62. Both K63- and K48-linked
ubiquitylation were responsible for the p62 modification to a similar
extent (Fig. 5C). Both wild-type and mutated forms of EGFP–
TRIM32 co-precipitated with Myc–p62, which is in line with the
GST-pulldown (Fig. 2) and Duolink assay (Fig. 4) results. Hence,
the disease mutations do not impair the p62–TRIM32 interaction
in cells. Similar ubiquitylation of p62 was obtained when
co-transfecting Myc–p62 and wild-type or P130S EGFP–TRIM32
constructs in the HEK293 FlpIn TRIM32-KO cells (Fig. 5C). Myc–
p62 also formed a high-molecular-mass band in the SDS gel when
co-transfected with the active forms of TRIM32 (Fig. 5D),
suggesting that TRIM32-mediated ubiquitylation of p62 leads to
the formation of stable p62 oligomers. To identify whether impaired
ubiquitylation of p62 is a general trait of LGMD2H disease
mutations, the recently described V591M mutant of TRIM32
(Di Rienzo et al., 2019) was co-transfected with Myc–p62 in the
HEK293 FlpIn TRIM32-KO cells (Fig. 5E). Introduction of the
V591M mutation strongly impaired the p62 ubiquitylation, clearly
pointing towards aberrant ubiquitylation of p62 as a general
phenotype of LGMD2H. Western blotting of the Myc–p62
precipitates using an antibody against mono-and poly-ubiquitin
(FK2) verified that p62 ubiquitylation was strongly reduced upon
introduction of the LGMD2H disease mutations D487N and
V591M (Fig. 5E).
Next, we undertook mass spectrometry (MS) analysis to identify
which lysine residues in p62 were modified by TRIM32.
MS analysis of Myc–p62 immunoprecipitated from HEK293
TRIM32-KO cells co-transfected with Myc–p62 and EGFP–
TRIM32, or the TRIM32 disease mutants EGFP–TRIM32P130S
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and EGFP–TRIM32D487N, revealed that co-expression of wild-type
TRIM32 and the BBS11 disease mutant lead to ubiquitylation of
p62 at two lysine residues, K157 and K295 (Fig. 5F,G). No lysine
residue was found to be ubiquitylated when the LGMD2H disease
mutant was co-expressed with p62. To verify ubiquitylation on
these two residues, we introduced K157R or K295R single
and double mutations into p62. However, these mutations did not
abolish TRIM32 mediated mono-ubiquitylation (Fig. S3A,B).
Mono-ubiquitylation of endogenous p62 under ubiquitin stress is
reported to occur on p62K157 and p62K295, together with p62K313 and
p62K420 (Peng et al., 2017); in that study, mono-ubiquitylation of
p62 at those residues was proposed to inhibit formation of inactive
p62 dimers with ‘closed’ UBA domains, and thereby promote p62–
polyubiquitin interactions and autophagy activity. Hence, next we
established a p62K157R/K295R/K420R triple mutant and subjected it to
TRIM32, but still TRIM32 was able to mediate ubiquitylation of
Fig. 5. TRIM32 wild-type, but not the LGMD2H disease mutant, mono-ubiquitylates p62. (A) Western blot of two independent experiments from lysates of
HEK293 p62-KO cells co-expressingMyc–p62 with EGFP–TRIM32. Myc–p62was immunoprecipitated (IP) using aMyc-trap and precipitated p62 detected using
an anti-Myc antibody. The EGFP–TRIM proteins were detected using an anti-GFP antibody. * indicates mono-ubiquitylated Myc–p62 and EGFP–TRIM32.
(B) Myc–p62 was co-expressed with EGFP–TRIM32 and HA–ubiquitin, and with mCherry–USP2, where indicated, in the HEK293 p62-KO cell line. Myc–p62 was
immunoprecipitated using a Myc-trap and precipitated p62 detected using an anti-Myc antibody. The EGFP–TRIM proteins were detected using an anti-GFP
antibody. * indicates mono-ubiquitylated Myc–p62 and EGFP–TRIM32. (C) Myc–p62 was co-transfected with HA–Ub-K48 or HA–Ub-K63 in the HEK293
EGFP–TRIM32WT, EGFP–TRIM32P130S and EGFP–TRIM32D487N cell lines and expression induced by tetracyclin (1 µM) for 24 h. Myc–p62 was
immunoprecipitated using a Myc-trap and precipitated p62 detected using an anti-Myc antibody. The EGFP–TRIM proteins were detected using an anti-GFP
antibody. * indicates mono-ubiquitylated p62 and mono-ubiquitylated EGFP–TRIM32. (D) Myc–p62 was co-transfected with EGFP–TRIM32WT, EGFP–
TRIM32P130S or EGFP–TRIM32D487N in the HEK293 TRIM32-KO (#1) cell line. Myc-p62 was immunoprecipitated using a Myc-trap and precipitated p62
detected using an anti-Myc antibody. The EGFP–TRIM proteins were detected using an anti-GFP antibody. * indicates mono-ubiquitylated p62 and a high-
molecular-mass form of p62. (E) Myc–p62 was co-transfected with EGFP–TRIM32WT, EGFP–TRIM32P130S, EGFP–TRIM32D487N, EGFP–TRIM32V591M, or
EGFP–TRIM32 and mCherry–USP2 in the HEK293 TRIM32-KO (#1) cell line. Myc–p62 was immunoprecipitated using a Myc-trap and precipitated p62
detected using an anti-Myc antibody. Ubiquitin modification of p62 was detected using an antibody recognizing mono- and poly-ubiquitin (FK2) (lower panels).
The EGFP–TRIM proteins were detected using an anti-GFP antibody. * indicates mono-ubiquitylated p62 and a high-molecular-mass p62. In all blots, EGFP
indicates a control plasmid expressing only EGFP. (F) Schematic of p62 domain organization with location of the two lysine residues mapped to be ubiquitylated
by TRIM32 indicated above. ZZ, Zinc finger; NLS, Nuclear localization signal; EIR, E2-interacting region; LIR, LC3-interacting region; KIR, Keap1-interacting
region; UBA, Ubiquitin-binding domain. (G) Sequence of the p62 peptides found to be ubiquitylated by TRIM32 by MS analyses.
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p62 (Fig. S3B). Neither did introduction of the single K165R or
K313R mutations, or the four mutations p62K157R/K295R/K313R/K420R
impair ubiquitylation (Fig. S3B). These results indicate that
TRIM32-mediated ubiquitylation of p62 may happen at several
lysine residues. Interestingly, introducing the D69A mutation in
p62, which impairs its ability to undergo oligomerization (Lamark
et al., 2003), abolished the TRIM32-mediated mono-ubiquitylation
(Fig. S3A,B). This indicates that TRIM32 recognize and ubiquitylate
oligomerized p62, but not monomeric p62 molecules.
TRIM32 enhances the formation and turnover of p62 dots
To assess the impact of TRIM32 on the early autophagy events, we
assayedWIPI-dot formation in the TRIM32-KO cell lines compared
to wild-type cells in normal and starvation conditions. The
TRIM32-KO cells did not display any strong effect on the
formation of WIPI dots upon starvation (Fig. S3C). However,
confocal analysis of p62 in the TRIM32-KO cells showed that the
ability of p62 to form dots was significantly reduced (Fig. 6A,B).
This suggests that TRIM32-mediated mono-ubiquitylation of p62
stimulates the formation of p62 dots and its autophagic activity, in
line with previous studies of the roles of p62 ubiquitylation
(Conway and Kirkin, 2017; Lee et al., 2017; Peng et al., 2017). In
order to verify this further, we reconstituted the TRIM32-KO cell
lines with stably expressing Myc–TRIM32WT, Myc–TRIM32P130S
and Myc–TRIM32D487N, and monitored the formation of p62 dots
under normal conditions and upon inhibition of autophagy activity
by BafA1 treatment (Fig. 6C–F). Conclusively, we found that
reintroduction of TRIM32 in the TRIM32-KO cell line strongly
facilitated the formation of p62 dots. The number of p62 dots
was enhanced upon BafA1 treatment, indicating that TRIM32
augments the autophagic degradation of p62. Importantly,
reconstitution with the TRIM32P130S mutant facilitated p62 dot
formation nearly as efficiently as TRIM32WT, while reconstitution
with the TRIM32D487N mutant had no effect on p62 dot formation
(Fig. 6F). This clearly indicates that the E3 ligase activity of
TRIM32 is important for its regulatory role on p62. Interestingly, in
the TRIM32-KO cells reconstituted with Myc–TRIM32, most cells
displayed a diffuse cytoplasmic localization of TRIM32 –with only
a few cells containing TRIM32 dots. This was in contrast to the
HEK293 FlpIn cells stably overexpressing EGFP–TRIM32. Here,
wild-type TRIM32 and the BBS11 disease mutant were found to
form cytoplasmic dots in most cells. The more diffuse localization
pattern in the reconstituted TRIM32-KO cells suggests that high
expression levels of TRIM32 leads to the formation of cytoplasmic
dots. However, the dot formation seems to be dependent on
TRIM32 ubiquitylation, since the catalytic dead TRIM32 and the
LGMD2H disease mutation were mainly diffuse. Importantly,
BafA1 treatment of the reconstituted TRIM32-KO cells resulted in
formation of several cytoplasmic dots in the cells expressing
wild-type Myc–TRIM32 and the BBS11 disease mutant. Myc–
TRIM32WT and Myc–TRIM32P130S colocalized with p62 and
LC3B in these dots (Fig. 6E). In addition, Myc–TRIM32D497N
formed large cytoplasmic dots in some cells. However, these did not
colocalize with p62 and LC3B (Fig. 6E). To conclude, our data
show that TRIM32 can act as a positive regulator of p62
sequestration and degradation. Concomitantly, TRIM32 itself is a
p62 cargo, and thus will be directed to degradation by an active p62.
This creates a negative-feedback loop in the TRIM32–p62
interaction pathway (Fig. 6G). Hence, TRIM32-mediated
ubiquitylation of p62 seems to regulate its autophagic activity,
and thereby cellular proteostasis. One mechanism for the
LGMD2H disease can thus be explained by diminished p62
mono-ubiquitylation and lower p62-mediated autophagy activity,
resulting in impaired proteostasis.
DISCUSSION
Owing to constant mechanical stress, striated muscle proteins are
particularly prone to wear and tear, and require several protein
quality-control mechanisms to coordinate protein turnover and
removal of damaged proteins. Among these, ubiquitin signaling
and the autophagy-lysosomal pathways are important players
(reviewed in Dong and Cui, 2018). Here, we identified the E3
ubiquitin ligase TRIM32 as a substrate for the autophagy receptor
p62, which targets TRIM32 for degradation by selective autophagy.
Interestingly, TRIM32 was identified as one of the proteins rapidly
degraded upon starvation together with the autophagy receptor
proteins and certain other proteins (Mejlvang et al., 2018). However,
the disease mutant of TRIM32 associated with LGMD2H was not
degraded by autophagy. Furthermore, we found TRIM32 to bind
directly to p62 and mediate mono-ubiquitylation on several lysine
residues, among them p62K157 and p62K295. In addition, the TRIM32
LGMD2H disease mutant D487N bound directly to p62. However,
TRIM32D487N did not mediate ubiquitylation of p62. Mono-
ubiquitylation of p62 is proposed to enhance its autophagy receptor
potential, which is critical for maintaining proteostasis during cellular
stress (Peng et al., 2017). We found the formation of p62 bodies to be
reduced in TRIM32-KO cells, while it was strongly facilitated when
TRIM32WT or TRIM32P130S was reintroduced into the knockout
cells. Importantly, the LGMD2H disease mutation was not able to
rescue p62 dot formation in the TRIM32-KO cells. Together, this
implicates TRIM32 as a positive regulator of p62-mediated selective
autophagy, and suggests that one mechanism for development of
LGMD2H in TRIM32D487N muscle cells is due to reduced p62
autophagy activity leading to dysregulated cellular proteostasis.
Several TRIM proteins have been shown to modulate the
selective autophagy process (Chauhan et al., 2016; Fusco et al.,
2018; Jena et al., 2018; Kimura et al., 2015, 2016; Mandell et al.,
2014), and during the completion of this paper Di Rienzo and
co-workers (2019) identified TRIM32 as a regulator of ULK1
activity in atrophic muscle cells. Similarly to ULK1, p62 activity
during selective autophagy is regulated by ubiquitylation. TRIM21
and NEDD4 are reported to mediate ubiquitylation of p62K7 leading
to suppressed protein sequestration and induced inclusion body
autophagy (Lin et al., 2017; Pan et al., 2016). The E3 ligase
RNF166 ubiquitylates p62 at K91 and K189, facilitating the role of
p62 in xenophagy (Heath et al., 2016), while RNF26 ubiquitylates
p62 within the UBA domain facilitating TOLLIP interaction and
vesicular cargo sorting (Jongsma et al., 2016). Keap1–Cullin3
poly-ubiquitylates p62K420 leading to diminished p62 sequestration
and degradation activity (Lee et al., 2017). The E2 conjugating
enzymes UBE2D2 and UBE2D3 are found to bind directly to p62
via the E2-interacting region (EIR) (Fig. 5E), and mediate mono-
ubiquitylation of p62 at several lysine residues, among them K157,
K295 and K420, upon ubiquitin stress signaling (Peng et al., 2017).
This mono-ubiquitylation is proposed to relieve the inhibition of the
UBA domain in the p62 UBA dimer, leading to enhanced binding
and tethering of ubiquitylated cargoes to ATG8 proteins conjugated
to the phagophore (Conway and Kirkin, 2017). Here, we mapped a
direct interaction between TRIM32 and p62 that was independent of
the PB1 domain and the UBA domain, similar to the p62 interaction
with Keap1–Cullin3. However, Keap1–Cullin3 poly-ubiquitylated
p62 at K420 in the UBA domain, while we found TRIM32
to mediate mono-ubiquitylation of p62 at K157 and K295. The
Keap1–Cullin3-mediated ubiquitylation of p62 increases p62
10













inclusion body formation and subsequent degradation, which is
proposed to be a mechanism for Keap1 to release the antagonistic
role of p62 and thereby dampen the NRF2-mediated response to
oxidative stress (Lee et al., 2017). On the other hand, mono-
ubiquitylation of p62 at several residues, including K157, K295 and
K420, enhances p62 body formation and p62-mediated autophagy
activity. This is proposed to be critical for homeostasis during
various cellular stresses.
We show that introduction of the LGMD2H disease mutation in
TRIM32 makes it unable to mono-ubiquitylate p62. The D487N
Fig. 6. See next page for legend.
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mutation located in the evolutionarily conserved NHL region of
TRIM32 does not inhibit binding to p62. Previously, the LGMD2H
mutant is reported to have impaired oligomerization and E3 ligase
activity and to display a more diffuse cytoplasmic localization than
TRIM32 WT and TRIM32P130S that are enriched in puncta/
aggregates in most cells (Locke et al., 2009). Also, the LGMD2H
disease mutants seem to be less expressed in muscle tissues from
affected patients (Servián-Morilla et al., 2019). Apart from that, the
molecular mechanisms of TRIM32 mutants causing the LGMD2H
and BBS11 diseases are far from being understood. It is not known
if the self-mono-ubiquitylation is important for activation of
TRIM32. Our results suggest that this may be the case, and also
that this mono-ubiquitylation is important for degradation of
TRIM32 via selective autophagy. Several reports connect
TRIM32 ubiquitylation activity to substrates whose deregulation
might influence the onset and progression of muscular dystrophy,
including actin, tropomyosin, troponins, α-actinin, dysbindin and
c-Myc (reviewed in Tocchini and Ciosk, 2015). Interestingly, p62 is
strongly implicated in chaperone-assisted selective autophagy
(CASA), which is essential for muscle maintenance (Arndt et al.,
2010). Dysregulated CASA resulted in Z-disk disintegration and
progressive muscle weakness. Here, we found that the TRIM32
mutation implicated in muscle dystrophy is unable to ubiquitylate
p62 at lysine residues that are linked to p62-mediated substrate
sequestration and autophagy activity. Furthermore, TRIM32-KO
cells displayed a reduced capacity for p62 sequestration upon
cellular stress induced by starvation. Hence, LGMD2Hmutations in
TRIM32 lead to impaired substrate ubiquitylation and impaired
degradation via p62-mediated selective autophagy, both important
players in cellular proteostasis. These findings contribute to the
understanding of the pathological mechanisms of LMGD2H.
The TRIM32-mediated ubiquitylation site p62K157 is located in
the zinc-finger (ZZ) domain (Fig. 5E), and this lysine residue is
evolutionarily conserved from zebrafish to human. Recently the
small non-coding RNA molecule Vault RNA1-1 was found to bind
to the ZZ domain of p62 and thereby modulate its dimerization and
autophagy activity (Horos et al., 2019). Hence, post-translational
modifications in the ZZ domain could impact such interactions and
thereby p62-mediated autophagy activity. The p62K295 site lies at
the border of the EIR and of a previously predicted PEST sequence.
Thus, it can be speculated that this modification can regulate
interactions with ubiquitin E2 enzymes, but also have an impact on
p62 stability. The latter can thereby explain the reduced expression
level of p62 detected in muscle tissue isolated from LGMD2H
patients (Servián-Morilla et al., 2019).
In addition to being a positive regulator of p62 activity, this study
revealed that TRIM32 is a p62 substrate in selective autophagy
(Fig. 6G). TRIM32 first facilitates p62-mediated autophagy activity.
This, after a certain period, leads to a reduced TRIM32 expression
caused by p62-mediated degradation. Diminished TRIM32
expression will in turn lead to declined p62 activity, creating a
negative-feedback loop. This negative-feedback mechanismmay be
a potential target for therapeutic intervention.
MATERIALS AND METHODS
Antibodies and reagents
The following primary antibodies were used: rabbit polyclonal antibody
for TRIM32 (Proteintech, 10326-1-AP; 1:2000); rabbit polyclonal anti-GFP
(Abcam, ab290; 1:5000); mouse monoclonal Myc-Tag (9B11) [Cell
Signaling Technologies, #2276; 1:2000 for western blotting (WB), 1:200
for immunofluorescence (IF)]; rabbit polyclonal anti-LC3B (Sigma, L7543;
1:1000 for WB, 1:500 for IF); rabbit polyclonal antibody for phospho-
4E-BP1 (Cell Signaling Technologies, #9451; 1:1000); rabbit polyclonal
anti-actin (Sigma, A2066; 1:1000); mouse monoclonal anti-p62 lck ligand
(BD Biosciences, 610833; 1:2000); guinea pig polyclonal anti-p62 (Progen,
GP62-C; 1:2000); mouse monoclonal anti-ubiquitin (FK2) (BIOMOL,
PW8810, 1:1000) and mouse monoclonal anti-PCNA (DAKO, M0879;
1:1000). The following secondary antibodies were used: horseradish-
peroxidase (HRP)-conjugated goat anti-rabbit-IgG (BD Biosciences,
554021; 1:2000); HRP-conjugated goat anti-mouse-Ig (BD Biosciences,
554002; 1:2000); and HRP-conjugated anti-biotin antibody (Cell Signaling
Technologies, #7075; 1:2000). The following fluorescent secondary
antibodies were used: Alexa Fluor® 488-conjugated goat anti-mouse-IgG
(Life Technologies, A-11029; 1:1000); Alexa Fluor® 488-conjugated goat
anti-rabbit-IgG (Life Technologies, A-11008; 1:1000); Alexa Fluor® 555-
conjugated goat anti-rabbit-IgG (Life Technologies, A-11008; 1:5000);
Alexa Fluor® 555-conjugated goat anti-guinea-pig-IgG (Life Technologies,
A-21435; 1:1000); Alexa Fluor® 555-conjugated goat anti-mouse-IgG (Life
Technologies, A-21424; 1:1000); Alexa Fluor® 647-conjugated goat anti-
guinea pig IgG (Life Technologies, A-21450; 1:1000). The reagents used
were: BafA1 (Sigma, B1793); MG132 (Sigma, C2759); tetracycline
(Sigma, #87128); doxycycline (Sigma, D9891); and Hanks balanced salt
solution (Sigma, H8264).
Cell culture and transfections
HeLa (ATCC, CCL2), HEK293 (ATCC, CRL-1573) and Hek293 T-Rex
(Thermo Fisher Scientific, R714-07) cells were cultured in Dulbecco’s
modified Eagle’s medium (DMEM) (Sigma, D6046) with 10% fetal bovine
serum and 1% streptomycin-penicillin (Sigma, P4333). Hek FlpIn T-Rex
cells with integrated TRIM32, TRIM32 C44S, TRIM32 P130S or TRIM32
D487N were grown in the same medium with additional selection
marker antibiotics, 200 µg/ml hygromycin B (Invitrogen, #10687010) and
7.5 µg/ml blasticidin (Gibco, A1113903). Sub-confluent cells were
transfected using TransIT-LT1 (Mirus, MIR2300) or Metafectene Pro
(Biontex, T040) following the manufacturer’s instructions. All cell lines
were routinely tested for mycoplasma contamination.
Fig. 6. TRIM32 enhances the formation and turnover of p62 dots.
(A) Immunostaining of endogenous p62 in HEK293 FlpIn cells and the two
TRIM32 KO clones under normal (FM) and starvation (SM) conditions
(HBSS 2 h). Scale bars: 10 µm. (B) Quantification of p62 dots in the two
TRIM32 KO clones and the HEK293 FlpIn wild type cell line under normal (FM)
and starvation (SM) (HBSS 2 h) conditions using the Volocity software
(PerkinElmer). Each graph represents the mean±s.d. of the relative number of
p62 dots per cell (normalized to the value for FM in wild-type cells). The results
are from three independent experiments each including ∼100 cells per
condition. P-values were obtained using Student’s t-test. (C) Immunostaining
of endogenous p62 in the TRIM32 KO (#1) cell line and TRIM32 KO (#1) cells
reconstituted with stable expression of Myc–TRIM32WT, Myc–TRIM32P130S or
Myc–TRIM32D487N as indicated. The cells are grown in FM with BafA1 (2 µM,
7 h). Scale bars: 10 µm. (D) Western blot showing the expression of
Myc–TRIM32, Myc–TRIM32P130S and Myc–TRIM32D487N in the reconstituted
HEK293 TRIM32-KO cell lines, grown in FM. * indicates mono-ubiquitylated
TRIM32. (E) Upper panels show immunostaining of Myc–TRIM32WT, p62 and
LC3B in the reconstituted HEK293 TRIM32-KO cells grown in normal medium
supplemented with BafA1 (2 µM) for 7 h. The circles exemplify colocalization of
all three proteins in BafA1 dots. The lower panels show merged images of
similar immunostainings in the TRIM32-KO cell line reconstituted with Myc–
TRIM32P130S or Myc–TRIM32D487N. Images were obtained using a ZEISS780
confocal laser scanning microscope, and the colocalization line plots to the
right obtained using the ZEN software. Scale bars: 10 µm. (F) Quantification of
p62 dots in the cell lines represented in C, under normal (FM) and normal plus
BafA1 (7 h) conditions, and starvation (SM) (HBSS 4 h) and starvation plus
BafA1 conditions. The graphs represent the mean±s.d. of the relative number
of p62 dots per cell (normalized to the value for FM in TRIM32-KO cells)
quantified using Volocity software (PerkinElmer). The results are from three
independent experiments each including n>100 cells per condition. *P<0.05,
**P<0.005, ***P<0.0005; n.s., not significant (Student’s t-test). (G) A model
depicting the roles of TRIM32 both as a p62 activator and a p62 substrate
in selective autophagy. ZZ, zinc finger; UBA, ubiquitin-binding domain;
Ub, Ubiquitin.
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All plasmids used in this study are listed in Table S1. Plasmids were made by
conventional restriction enzyme-based cloning or by use of the Gateway
recombination system (Thermo Fisher Scientific). Gateway LR reactions
were performed as described in the instruction manual. Point mutation was
carried out using the site-directed-mutagenesis kit from Stratagene. PCR
and sequencing oligonucleotides (Table S2) were ordered from Thermo
Fisher Scientific. All plasmids were verified by restriction enzyme digestion
and DNA sequencing (BigDye, Applied Biosystems, 4337455). All TRIM
proteins were cloned into the pDest mCherry-EYFP (Bhujabal et al., 2017)
double tag vector.
Recombinant protein production and GST-pulldown analysis
GST or GST-tagged proteins were expressed in Escherichia coli strain
SoluBL21 (Genlantis, #C700200). Protein expression was induced by
treating overnight bacterial culture with 50 µg/ml isopropyl β-D-1-
thiogalactopyranoside (IPTG). GST or GST fusion proteins were purified
and immobilized on glutathione–Sepharose 4 Fast Flow beads (GE Healtcare,
17-5132-01). Myc-tagged proteins were in vitro translated using the TNT T7
reticulocyte Lysate system (Promega, #14610) in the presence of
[35S]methionine. In vitro translated protein or total cell lysate was pre-
incubatedwith 10 µl glutathione–Sepharose beads and 100 µl ofNETNbuffer
(50 mM Tris-HCl pH 8.0, 150 mM NaCl, 1 mM EDTA and 0.5% Nonidet
P-40) with cOmplete Mini EDTA-free protease inhibitor mixture tablets
(Roche Applied Science, 11836170001) for 1 h at 4°C to reduce unspecific
binding. Pre-incubated lysate was then incubated with the immobilized GST
fusion protein for 2 h at 4°C. Beads were washed five times with NETN
buffer, boiled with 2× SDS gel loading buffer (125 mMTris-HCl pH 7.5, 4%
SDS, 0.04%Bromophenol Blue, 8% sucrose and 100 mMdithiolthreitol) and
subjected to SDS-PAGE. Gels were stained with Coomassie Brilliant Blue
R-250 Dye (Thermo Fisher Scientific, #20278) to visualize GST fusion
proteins and then vacuum dried. Signals from 35S-labeled proteins were
detected with a Fujifilm bioimaging analyzer BAS-5000 (Fujifilm).
Immunoblotting and immunoprecipitation
Cells were seeded in 6-cm plates and treated as indicated. Cells were lysed in
1× SDS buffer (50 mM Tris-HCl pH 7.4, 2% SDS and 10% glycerol)
supplementedwith 200 mMdithiothreitol (DTT, Sigma, #D0632) and heated
at 100°C for 10 min. Protein concentration was measured using the Pierce
BCA protein assay kit (Thermo Fisher Scientific, #23227). Equal amounts of
protein were resolved by SDS-PAGE and transferred to nitrocellulose
membrane (Sigma, GE10600003). The membrane was stained with Ponceau
S (Sigma, P3504), blocked with 5% non-fat dry milk in 1% TBS-T [0.2 M
Tris-HCl pH 8, 1.5 M NaCl and 0.05% Tween 20 (Sigma, P9416)] and then
incubated with indicated primary antibodies for 24 h. The membrane was
washed three times for 10 min each with TBS-T followed by incubation with
secondary antibody for 1 h. The membrane was washed three times for
10 min and analyzed by enhanced chemiluminescence using the ImageQuant
LAS 4000 (GE Lifescience). For immunoprecipitation, cells were lysed in
modified radioimmunoprecipitation assay (RIPA) buffer (50 mM Tris
pH 7.5; 150 mM NaCl; 1 mM EDTA; 1% NP40; 0.25% Triton-X-100)
supplemented with cOmplete Mini EDTA-free protease inhibitor cocktail
tablets (Roche, #11836170001) and phosphatase inhibitor cocktail (Merck
Millipore, #524625) by shaking at 4°C for 30 min. The cell lysate was
centrifuged at 10,000 g for 10 min. The resulting supernatant was incubated
with antibody to endogenous protein for endogenous immunoprecipitation or
with Myc-TRAP (Chromotek, yta-20) for cells stably expressing, or
transiently transfected, with Myc-tagged proteins. They were washed five
times in RIPA buffer before boiling in 2× SDS gel loading buffer. This was
followed by protein identification by immunoblotting as previously
described but on Immobilon-FL PVDF membrane (Millipore, IPFL00010),
blocked with Odyssey® blocking buffer (PBS) (LI-COR Biosciences,
#927-40000) and scanned on Odyssey CLx Imager (LI-COR).
Mass spectrometry
Cells were directly lysed in lysis buffer (Myc-TRAP®_A; Chromotek)
supplemented with cOmplete Mini EDTA-free protease inhibitor (Roche),
5 mM NAM (N-Arachidonylmaleimide; Sigma) and 10 mM NEM
(N-ethylmaleimide; Sigma). Immunoprecipitation of Myc-tagged proteins
was performed according to the supplier’s protocol (Chromotek). The
samples were fractionated by SDS-PAGE followed by SimplyBlue™
SafeStain (Thermo Fisher Scientific) staining. The lanes representing
proteins of molecular masses within 55–80 kDawere cut from the gel. In-gel
trypsin digestion was performed before analysis by high-performance liquid
chromatography–tandem mass spectrometry (HPLC-MS/MS). Gel pieces
were subjected to in-gel reduction, alkylation and tryptic digestion using
6 ng μl−1 trypsin (V511A; Promega). OMIX C18 tips (Varian) were used
for sample cleanup and concentration. Peptide mixtures containing 0.1%
formic acid were loaded onto a Thermo Fisher Scientific EASY-nLC1200
system. Samples were injected to a trap column (Acclaim PepMap
75 μm×2 cm, C18, 3 μm, 100 Å; Thermo Fisher Scientific) for desalting
before elution to the separation column (EASY-Spray column, C18, 2 μm,
100 Å, 50 μm, 50 cm; Thermo Fisher Scientific). Peptides were fractionated
using a 4–40% gradient of increasing amounts of 80% acetonitrile in water
over 60 min at a flow rate of 300 nl/min. The mobile phases contained 0.1%
formic acid. Separated peptides were analyzed using an Orbitrap Fusion
Lumos mass spectrometer. The mass spectrometer was operated in a data-
dependent mode with the precursor scan in the orbitrap over the range m/z
350–1500. The most-intense ions were selected for electron-transfer
dissociation (ETD) or collision-induced dissociation (CID) fragmentation
using 3 s between each master scan. Dynamic exclusion was set to 30 s. The
Orbitrap AGC target was set to 4E5, and the MS2 scans in the Ion Trap were
set to 1E4 with maximum injection times 50 and 100 ms, respectively.
Precursor ions with charge 3+ in them/z range 350–650 and 4+ or 5+ ions in
the m/z range 350–900 were fragmented with ETD. All ions with 6+ or
higher were also fragmented using ETD. The rest of the precursor ions were
fragmented using CID. Protein identification and post-translational
modification mapping was performed using the Proteome Discoverer 2.2
software (Thermo Fisher Scientific).
Immunostaining and fluorescence confocal microscopy
Subconfluent cells grown in 24-well plates on coverslips (VWR, #631-
0150) coated with fibronectin (Sigma, F1141) and treated as indicated. They
were fixed in 4% paraformaldehyde for 20 min to allow visualization of
acidic structures after the staining procedure. The cells were then
permeabilized with methanol at room temperature for 5 min, blocked in
5% goat serum in PBS or 5% BSA in PBS and incubated at room
temperature with a specific primary antibody followed by Alexa Fluor 488-,
555- or 647-conjugated secondary antibody and DAPI. Confocal images
were obtained using a 63× NA 1.4 oil immersion objective on an LSM780/
LSM800 system. Quantification of p62 dots were performed using the
Volocity software (Perkin Elmer) on 10 images per condition, in three
independent experiments. Each image contained 10–20 cells, and was
generated using the z-stack function in the ZEN software (Zeiss). The line-
profile tool in the ZEN software was exploited to plot colocalization of
EGFP–TRIM32 and immunostained p62 and LC3B. Quantification of cells
containing red only dots in the double-tagged screen was done manually by
two independent researchers in three independent experiments.
Generation of TRIM32- and p62-KO HEK293 FlpIn cell lines
To generate a knockout cell line for TRIM32, the CRISPR/Cas9 system was
exploited. The knockout was generated as described by Ran et al. (2013).
Guide RNAs (gRNA) as described in Table S2were annealed and ligated into
the vector pSpCas9(BB)-2A-GFP (PX458) (Addgene, #48138) using BbsI
restriction sites. Subconfluent Hek293 FlpIn T-Rex cells were transfected
with the targeting plasmids using Metafectene Pro (Biontex, T020). EGFP-
positive cells were sorted by FACS and plated into 96-well plates at 3 days
post transfection. Single colonies were expanded up to 12-well plates and
knockout validated by immunoblotting. Confirmed knockout clones were
further screened by genomic sequencing. The targeted genomic regions were
amplified by PCR using the primers TRIM32PCRfwand TRIM32PCRrv, or
p62 PCRfwand p62PCRrv (Table S2) and the resulting PCR products ligated
into the pGEM-T-EASy vector (Promega, A3600). Sequencing were
conducted for at least three clones for each PCR product.
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Reconstitution of TRIM32-KO cell lines
The TRIM32-KO cell lines were transduced using the lentiviral-based
GATEWAY destination vector pCDH-EF1a-Myc-IRES conferring
puromycine resistance. This vector enables constitutive expression of
Myc–TRIM32WT, Myc–TRIM320P130S or Myc–TRIM32D487N under
control of an EF1α promoter.
Generation of stable cell lines
Stable cell lines were generated using the FlpIn T-Rex system (Thermo
Fisher Scientific, R71407). cDNAs were PCR amplified and ligated into the
inducible FlpIn expression vector, pDest-EGFP-Flp-In (Alemu et al., 2012).
FlpIn T-Rex cells were then co-transfected with the cDNA-containing FlpIn
expression vector and the FlpIn recombinase vector pOG44 in the ratio of
1:3. Cells were selected by treatment with 200 µg/ml hygromycin B
(Invitrogen, #10687010) and 7.5 µg ml−1 blasticidin (Gibco, A1113903),
and protein expression verified by induction with tetracycline (Sigma,
#87128) or doxycycline (Sigma, D9891).
Flow cytometry
Hek293 FlpIn TRIM32WT, P130S and D487N cells in 12-well plates were
trypsinized (Sigma, T4049) and passed through cell strainer caps (BD
Biosciences, 352235) to obtain single-cell suspensions. Cells were analyzed
on a FACSAria cell sorter running FACSDiva software version 5.0 (BD
Biosciences) using the blue laser for excitation of GFP. GFP fluorescence
was collected through a 530/30 nm bandpass filter in the E detector. Data
was collected from a minimum of 10,000 singlet events per tube, and the
median GFP-A value was used for quantification. All bar graphs show the
mean±s.d. of the GFP-A median values from three independent
experiments.
Proximity ligation assay
Subconfluent HEK293 FlpIn EGFP-TRIM32 cells were fixed with 4%
paraformaldehyde. Colocalization of EGFP–TRIM32 and endogenous p62
was detected by performing a Duolink® PLA (Sigma; DUO92101)
according to the manufacturer’s protocol. The primary antibodies rabbit
polyclonal anti-GFP (1:2000, Abcam, ab290) and mouse monoclonal anti-
p62 lck ligand (1:200, BD Biosciences, 610833) were incubated at 4°C
overnight. The signals were detected using a 63× NA 1.4 oil immersion
objective on an LSM780 system. Quantification of dots was performed
using the Volocity software (Perkin Elmer) on 10 images per condition, in
three independent experiments. Each image contained 10–20 cells, and was
generated using the z-stack function in the ZEN software (Zeiss).
Cell proliferation assay
Hek FlpIn TRIM32 KO Clone #1, KO Clone #2 and FlpIn T-Rex control
cells were seeded with four different concentrations (2000, 4000, 6000 and
8000 cells) in 100 μl DMEM (Sigma, D6046) on E-Plate L16 PET readers
(ACEA Biosciences Inc, #2801185). xCELLigence® Real-Time Cell
Analysis (RTCA) (ACEA Biosciences) were used to measure the cell
proliferation over a time of 96 h with recording at 1 h intervals.
Statistics
All experiments were repeated at least three times, unless otherwise
specified. Error bars represent the s.d. or s.e.m. as indicated in figure
legends, and two-sided unpaired, homoscedastic Student’s t-tests were
performed to assess significant differences between populations. Replicates
were not pooled for statistical analyses. *P<0.05, **P<0.005 and
***P<0.0005; n.s. denotes not signififcant (P>0.05). Sample sizes are
denoted in the figure legends.
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Horos, R., Büscher, M., Kleinendorst, R., Alleaume, A.-M., Tarafder, A. K.,
Schwarzl, T., Dziuba, D., Tischer, C., Zielonka, E. M., Adak, A. et al. (2019).
The small non-coding vault RNA1-1 acts as a riboregulator of autophagy.Cell 176,
1054-1067.e1012. doi:10.1016/j.cell.2019.01.030
Isogai, S., Morimoto, D., Arita, K., Unzai, S., Tenno, T., Hasegawa, J., Sou, Y.-S.,
Komatsu, M., Tanaka, K., Shirakawa, M. et al. (2011). Crystal structure of the
ubiquitin-associated (UBA) domain of p62 and its interaction with ubiquitin. J. Biol.
Chem. 286, 31864-31874. doi:10.1074/jbc.M111.259630
Itakura, E. and Mizushima, N. (2011). p62 Targeting to the autophagosome
formation site requires self-oligomerization but not LC3 binding. J. Cell Biol. 192,
17-27. doi:10.1083/jcb.201009067
Jain, A., Lamark, T., Sjøttem, E., Larsen, K. B., Awuh, J. A., Øvervatn, A.,
McMahon, M., Hayes, J. D. and Johansen, T. (2010). p62/SQSTM1 is a target
gene for transcription factor NRF2 and creates a positive feedback loop by
inducing antioxidant response element-driven gene transcription. J. Biol. Chem.
285, 22576-22591. doi:10.1074/jbc.M110.118976
Jena, K. K., Kolapalli, S. P., Mehto, S., Chauhan, S. and Chauhan, S. (2018).
TRIM16 controls turnover of protein aggregates by modulating NRF2, ubiquitin
system, and autophagy: implication for tumorigenesis. Mol. Cell. Oncol. 5,
e1532251. doi:10.1080/23723556.2018.1532251
Jiao, J. and Demontis, F. (2017). Skeletal muscle autophagy and its role in
sarcopenia and organismal aging. Curr. Opin. Pharmacol. 34, 1-6. doi:10.1016/j.
coph.2017.03.009
Johansen, T. and Lamark, T. (2011). Selective autophagy mediated by autophagic
adapter proteins. Autophagy 7, 279-296. doi:10.4161/auto.7.3.14487
Jongsma, M. L. M., Berlin, I., Wijdeven, R. H. M., Janssen, L., Janssen, G. M. C.,
Garstka, M. A., Janssen, H., Mensink, M., van Veelen, P. A., Spaapen, R. M.
et al. (2016). An ER-associated pathway defines endosomal architecture for
controlled cargo transport. Cell 166, 152-166. doi:10.1016/j.cell.2016.05.078
Kimura, T., Jain, A., Choi, S. W., Mandell, M. A., Schroder, K., Johansen, T. and
Deretic, V. (2015). TRIM-mediated precision autophagy targets cytoplasmic
regulators of innate immunity. J. Cell Biol. 210, 973-989. doi:10.1083/jcb.
201503023
Kimura, T., Mandell, M. and Deretic, V. (2016). Precision autophagy directed by
receptor regulators - emerging examples within the TRIM family. J. Cell Sci. 129,
881-891. doi:10.1242/jcs.163758
Kimura, T., Jia, J., Kumar, S., Choi, S. W., Gu, Y., Mudd, M., Dupont, N., Jiang,
S., Peters, R., Farzam, F. et al. (2017). Dedicated SNAREs and specialized TRIM
cargo receptors mediate secretory autophagy. EMBO J. 36, 42-60. doi:10.15252/
embj.201695081
Kudryashova, E., Kudryashov, D., Kramerova, I. and Spencer, M. J. (2005).
Trim32 is a ubiquitin ligase mutated in limb girdle muscular dystrophy type 2H that
binds to skeletal muscle myosin and ubiquitinates actin. J. Mol. Biol. 354, 413-424.
doi:10.1016/j.jmb.2005.09.068
Kudryashova, E., Struyk, A., Mokhonova, E., Cannon, S. C. and Spencer, M. J.
(2011). The common missense mutation D489N in TRIM32 causing limb girdle
muscular dystrophy 2H leads to loss of the mutated protein in knock-in mice
resulting in a Trim32-null phenotype. Hum. Mol. Genet. 20, 3925-3932. doi:10.
1093/hmg/ddr311
Kudryashova, E., Kramerova, I. and Spencer, M. J. (2012). Satellite cell
senescence underlies myopathy in a mouse model of limb-girdle muscular
dystrophy 2H. J. Clin. Invest. 122, 1764-1776. doi:10.1172/JCI59581
Lamark, T., Perander, M., Outzen, H., Kristiansen, K., Øvervatn, A., Michaelsen,
E., Bjørkøy, G. and Johansen, T. (2003). Interaction codes within the family of
mammalian Phox and Bem1p domain-containing proteins. J. Biol. Chem. 278,
34568-34581. doi:10.1074/jbc.M303221200
Larsen, K. B., Lamark, T., Øvervatn, A., Harneshaug, I., Johansen, T. and
Bjørkøy, G. (2010). A reporter cell system to monitor autophagy based on p62/
SQSTM1. Autophagy 6, 784-793. doi:10.4161/auto.6.6.12510
Lazarou, M., Sliter, D. A., Kane, L. A., Sarraf, S. A., Wang, C., Burman, J. L.,
Sideris, D. P., Fogel, A. I. and Youle, R. J. (2015). The ubiquitin kinase PINK1
recruits autophagy receptors to induce mitophagy. Nature 524, 309-314. doi:10.
1038/nature14893
Lazzari, E. and Meroni, G. (2016). TRIM32 ubiquitin E3 ligase, one enzyme for
several pathologies: From muscular dystrophy to tumours. Int. J. Biochem. Cell
Biol. 79, 469-477. doi:10.1016/j.biocel.2016.07.023
Lee, Y. J., Chou, T.-F., Pittman, S. K., Keith, A. L., Razani, B. and Weihl, C. C.
(2017). Keap1/Cullin3 modulates p62/SQSTM1 activity via UBA domain
ubiquitination. Cell Rep. 20, 1994. doi:10.1016/j.celrep.2017.08.019
Lee, Y. J., Jonson, P. H., Sarparanta, J., Palmio, J., Sarkar, M., Vihola, A., Evilä,
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Table S1: Plasmids used in this study
pDONR221 TRIM32 Harvard HsCD00045116 
pDONR221 TRIM31 Harvard HsCD00040302 
pOTB7 TRIM47 Harvard HsCD00334690 
pBluescriptR TRIM45 Harvard HsCD00333612 
pENTR223 TRIM37 Harvard HsCD00365624 
pCMV-SPORT6 TRIM25 Harvard HsCD00330794 
pDNR-Dual TRIM1 Harvard HsCD00001917 
pDONR221 TRIM13 Harvard HsCD00044622 
pENTR223 TRIM9 Harvard HsCD00376162 
pDONR221 TRIM27 Harvard HsCD00042999 
pDONR221 TRIM29 Harvard HsCD00079683 
pDONR221 hTRIM5α (Mandell et al., 2016; Mandell et al., 2014) 
pDONR221 hTRIM56 V.Deretic 
pDONR221 hTRIM21 (Kimura et al., 2015) 
pDONR221 hTRIM23 V.Deretic 
pDONR221 hTRIM6 V.Deretic 
pDONR221 hTRIM49 V.Deretic 
pDONR221 hTRIM17 (Mandell et al., 2017) 
pDONR221 hTRIM22 V.Deretic 
pDONR221 hTRIM16 (Chauhan et al., 2016) 
pDONR221 hTRIM55 V.Deretic 
pDONR221 hTRIM20 (Kimura et al., 2015) 
pDest Myc-p62 (Lamark et al., 2003) 
pDest Myc-p62ΔUBA (Bjorkoy et al., 2005) 
pDest Myc-p62ΔPB1 (Bjorkoy et al., 2005) 
pDest Myc-p62 D69A (Lamark et al., 2003) 
pDest Myc-p62 K157R This study 
pDest Myc-p62 K165R This study 
pDest Myc-p62 K295R This study 
pDest Myc-p62 K313R This study 
pDest Myc-p62 K157R/K295R     This study 
pDest Myc-p62 K157R/K295R/K420R This study 
pRK5 HA-Ub-K48 (Lim et al., 2005) Addgene #17605 
pRK5 HA-Ub-K63 (Lim et al., 2005) Addgene #17606 
pDest EGFP-C1 (Lamark et al., 2003) 
pDest Myc (Lamark et al., 2003) 
pDest mCherry-EYFP (Bhujabal et al., 2017) 
pSPCas9(BB)-2A-GFP (PX458) (Ran et al., 2013) Addgene #48138 
pDest Myc TRIM32 P130S This study 
pDest Myc TRIM32 D487N This study 
pDest EGFP TRIM32 P130S This study 
pDest EGFP TRIM32 D487N This study 
pDest mCherry-EYFP TRIM32 P130S This study 
pDest mCherry-EYFP TRIM32 D487N This study 
pDest Myc TRIM32 (1-361) This study 
pDest Myc TRIM32 (362-653) This study 

























Table S2:  Oligonucleotides used in this study 








CRISPR TRIM32 T1A 5’CACCGGCACTGGCGGCAGATGGTA3’  
CRISPR TRIM32 T1B 5’CACCGCTATTGGCCAGTAGCATCAA3’ 
CRISPR TRIM32 T2A 5’CACCCCCGGAGGGCATCCAGGTTC3’ 
CRISPR TRIM32 T2B 5’CACCGCTAGAATGCCCCATCTGCA3’ 
TRIM32 PCRfw 5’GAATGACTGAATGACTGGTCATAGC3’ 
TRIM32 PCRrv 5’CCCACAGCCTCGCTGAGCCCAGCTG3’ 
CRISPR p62 guide 5’CACCGGCGCCTCCTGAGCACACGG3’ 
pP62 PCRfw 5’ACAGTGACGACAGAGGGGGA3’ 
p62 PCRrv 5’AATGCGAGCTTGGTGTGCC3’ 


























































































Figure S1: A) GST-pulldown assays using 35S-labeled Myc-TRIM32, Myc-TRIM32(1-361),
or Myc-TRIM32(362-653) and recombinant GST, GST-LC3B and GST-GABARAP 
immobilized on Glutathione Sepharose beads. B) Western blot of cell extracts from the 
HEK293 FlpIn cells with tetracycline inducible expression of EGFP-TRIM32WT, EGFP-
TRIM32P130S or EGFP-TRIM32D487N. Tetracyclin (1µg) was added for 24 hrs. Confocal
images of the same cell lines after 24 hrs with tetracyclin induced expression of the  EGFP-
TRIM32 proteins. Scale bar (10 µm). The * indicates an unidentified band. C) Western Blot
of cell extracts from HEK293 FlpIn cells and HEK293 FlpIn p62 Knock Out cells generated 
by CRISPR/Cas9. The cells were exposed to normal medium, normal medium plus BafA1 (2
µM) or normal medium plus MG132 (10 µM) for 2 hrs. D) Co-immunoprecipitation of
EGFP-TRIM32 and p62 using a GFP-TRAP on cell extracts from FlpIn EGFP-TRIM32 cells. 
Co-precipitated p62 was detected using an anti-p62 antibody, while GFP and EGFP-TRIM32 
were visualized by using an anti-GFP antibody. 
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Figure S2: A) C2C12 cells were transfected with mCherry-EYFP-TRIM32, mCherry-EYFP-
TRIM32P130S, mCherry-EYFP-TRIM32D487N, mCherry-EYFP-TRIM32R394H, and mCherry-
EYFP-TRIM32V591M as indicated, starved with HBSS (2 hrs) one day post transfection and 
imaged by a Zeiss800 confocal microscope. Images show representative cells from two 
independent experiments. Scale bar (10 µm). B) Western blot of cell extracts from
HEK293 FlpIn cells, HEK293 FlpIn cells with tetracyclin (1 g) induced expression of EGFP-
TRIM32, and clone #1 and #2 of the CRISPR/Cas9 mediated HEK293 FlpIn TRIM32 Knock 
Out cell lines. TRIM32 is visualized using an anti-TRIM32 antibody. Anti-Actin antibody 
staining is used as loading control. C) DNA sequences encompassing the pair of target 
sequences employed in the CRISPR/Cas9 mediated strategy generation TRIM32 KO#1 and 
TRIM32 KO#2 cell lines. The two lower parts show the DNA sequences of the PCR products 
obtained from the genomic loci targeted by CRISPR/Cas9. D) Proliferation curves of the 
HEK293 FlpIn cell line and the two TRIM32 KO clones obtained using xCELLigence RTCA 
system (ACEA Biosciences). The curves display the average of four independent wells, 
obtained from two independent experiments.  































































































































Figure S3: A) Myc-p62WT, myc-p62K157R, myc-p62K295R, or myc-p62D69A was coexpressed
with EGFP-TRIM32 and HA-Ubiquitin in the HEK293 p62 KO cell line. Myc-p62 was 
immunoprecipitated using a myc-trap and precipitated p62 detected using an anti-myc 
antibody. EGFP-TRIM was detected using an anti-GFP antibody. * indicates mono-
ubiquitylated myc-p62. B) Myc-p62WT, myc-p62K165R, myc-p62K313R, myc-p62K157R/K259R, myc-
p62K157R/K295R/K420, myc-p62D69A or p62K157R/K295R/K313R/K420 was coexpressed with EGFP-
TRIM32 in the HEK293 p62 KO cell line. Myc-p62 was immunoprecipitated using a myc-trap 
and precipitated p62 detected using an anti-myc antibody. EGFP-TRIM was detected using an 
anti-GFP antibody. * indicates mono-ubiquitylated myc-p62. C) The graph displays the 
quantitation of WIPI dots in the TRIM32 KO clone#1 and the HEK293 FlpIn wild type cell line 
under normal and starved (HBSS 2hrs) conditions using the Volocity software (PerkinElmer). 
Each graph represents the average of two independent experiments with standard deviations, 
each including around 100 cells per condition. 
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